(1)
Dermal Irritation, Sensitization, and Safety of Fixed-Dose Triple-Combination Clindamycin Phosphate 1.2% Benzoyl Peroxide 3.1% Adapalene 0.15% Gel in Healthy Participants. J of Skin 2023, 7 (4), s227. https://doi.org/10.25251/skin.7.supp.227.